The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets

被引:6
|
作者
Zakaria, Zaida [1 ]
Othman, Zaidatul Akmal [1 ,2 ]
Nna, Victor Udo [3 ]
Mohamed, Mahaneem [1 ,4 ]
机构
[1] Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
[2] Univ Sultan Zainal Abidin, Fac Med, Unit Physiol, Kuala Terengganu, Malaysia
[3] Univ Calabar, Coll Med Sci, Fac Basic Med Sci, Dept Physiol, Calabar, Nigeria
[4] Univ Sains Malaysia, Sch Med Sci, Unit Integrat Med, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
关键词
Medicinal plants; natural products; supplementation; hepatic lipid metabolism; non-alcoholic fatty liver disease; ELEMENT-BINDING PROTEIN-1C; ACTIVATED RECEPTOR-ALPHA; ADIPOSE TRIGLYCERIDE LIPASE; MESSENGER-RNA EXPRESSION; HORMONE-SENSITIVE LIPASE; ACETYL-COA CARBOXYLASE; DE-NOVO LIPOGENESIS; HIGH-FRUCTOSE DIET; INDUCED OBESE MICE; NF-KAPPA-B;
D O I
10.1080/13813455.2021.1939387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imbalance in hepatic lipid metabolism can lead to an abnormal triglycerides deposition in the hepatocytes which can cause non-alcoholic fatty liver disease (NAFLD). Four main mechanisms responsible for regulating hepatic lipid metabolism are fatty acid uptake, de novo lipogenesis, lipolysis and fatty acid oxidation. Controlling the expression of transcription factors at molecular level plays a crucial role in NAFLD management. This paper reviews various medicinal plants and their bioactive compounds emphasising mechanisms involved in hepatic lipid metabolism, other important NAFLD pathological features, and their promising roles in managing NAFLD through regulating key transcription factors. Although there are many medicinal plants popularly investigated for NAFLD treatment, there is still little information and scientific evidence available and there has been no research on clinical trials scrutinised on this matter. This review also aims to provide molecular information of medicinal plants in NALFD treatment that might have potentials for future scientifically controlled studies.
引用
收藏
页码:1262 / 1278
页数:17
相关论文
共 50 条
  • [21] Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
    Mato, Jose M.
    Alonso, Cristina
    Noureddin, Mazen
    Lu, Shelly C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (24) : 3009 - 3020
  • [22] Non-alcoholic fatty liver disease: pathogenesis and assessing the impact of dietary bioactive compounds on the liver
    Oguz, Esma
    Karakoyun, Berna
    MARMARA MEDICAL JOURNAL, 2024, 37 (02): : 115 - 120
  • [23] Citrulline counters hepatic lipid metabolism disorders in fructose-induced non-alcoholic fatty liver disease
    Jegatheesan, P.
    Beutheu, D. S.
    Ventura, G.
    Sarfati, G.
    Nubret, E.
    Kapel, N.
    Waligora-Dupriet, A. J.
    Cynober, L.
    De Bandt, J-P
    FEBS JOURNAL, 2014, 281 : 554 - 554
  • [24] EFFECT OF QUERCETIN TREATMENT ON LIPID METABOLISM DEREGULATION ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Pisonero-Vaquero, S.
    Garcia-Mediavilla, M. V.
    Martinez-Ferreras, A.
    Esteban-Blanco, M.
    Culebras, J. M.
    Garcia-Palomo, A.
    Olcoz, J. L.
    Gonzalez-Gallego, J.
    Sanchez-Campos, S.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 16 - 16
  • [25] Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease
    Weiss, Jonathan M.
    Palmieri, Erika M.
    Gonzalez-Cotto, Marieli M.
    Bettencourt, Ian A.
    Megill, Emily L.
    Snyder, Nathaniel W.
    McVicar, Daniel W.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [26] Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
    Ting Li
    Hua Yan
    Yan Geng
    Haitao Shi
    Hong Li
    Shenhao Wang
    Yatao Wang
    Jingyuan Xu
    Gang Zhao
    Xiaolan Lu
    Lipids in Health and Disease, 18
  • [27] Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease
    Su, Xin
    Kong, Yi
    Peng, Daoquan
    CLINICA CHIMICA ACTA, 2019, 498 : 30 - 37
  • [28] Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
    Liao, Chia-Jung
    Huang, Po-Shuan
    Chien, Hui-Tzu
    Lin, Tzu-Kang
    Yeh, Chau-Ting
    Lin, Kwang-Huei
    BIOMEDICINES, 2022, 10 (06)
  • [29] Non-Alcoholic Fatty Liver Disease Risk SNP Variants Affect Lipid Metabolism
    Ikezaki, Hiroaki
    Murata, Masayuki
    Shimono, Nobuyuki
    Schaefer, Ernst J.
    CIRCULATION, 2023, 148
  • [30] Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
    Li, Ting
    Yan, Hua
    Geng, Yan
    Shi, Haitao
    Li, Hong
    Wang, Shenhao
    Wang, Yatao
    Xu, Jingyuan
    Zhao, Gang
    Lu, Xiaolan
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (01)